Anti-inflammatory therapy and cardiovascular disease in inflammatory arthropathies : Effects of TNF-α antagonists on vascular function and structure
Appears in the following Collection
AbstractList of papers. Papers 1-3 are removed from the thesis due to copyright restrictions.
Paper 1. Angel K, Provan SA, Hammer HB, Mowinckel P, Kvien TK, Atar D. Changes in arterial stiffness during continued infliximab treatment in patients with inflammatory arthropathies. Fundamental & Clinical Pharmacology 2011;25:511-517. doi:10.1111/j.1472-8206.2010.00872.x
Paper 2. Angel K, Provan SA, Gulseth HL, Mowinckel P, Kvien TK, Atar D. Tumor Necrosis Factor-α antagonists improve aortic stiffness in patients with inflammatory arthropathies: A controlled study. Hypertension 2010;55:333-338. doi:10.1161/HYPERTENSIONAHA.109.143982
Paper 3. Angel K, Provan SA, Fagerhol MK, Mowinckel P, Kvien TK, Atar D. Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis and calprotectin in inflammatory arthropathies: A controlled study. American Journal of Hypertension 2012;25:644-650. doi:10.1038/ajh.2012.12
Paper 4. Angel K, Provan SA, Mowinckel P, Seljeflot I, Kvien TK, Atar D. The Larginine/ asymmetric dimethylarginine ratio is improved by anti-Tumor Necrosis Factor–α therapy in inflammatory arthropathies. Associations with aortic stiffness. NOTICE: this is the author’s version of a work that was accepted for publication in Atherosclerosis. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in: Atherosclerosis. 2012 Nov;225(1):160-5. doi:10.1016/j.atherosclerosis.2012.08.033